Get started
Author

S Magaz

Observed names: S. Magaz, Sol Magaz
Observed institution: Hospital Clínic de Barcelona
OpenAlex ID: A5002954710
The Burden of Migraine in Spain
2004 · Xavier Badia, Sol Magaz, et al. · PharmacoEconomics · 49
Cost-Effectiveness Analysis of PMMA, Silicone, or Acrylic Intra-Ocular Lenses in Cataract Surgery in Four European Countries
2005 · Andrew F. Smith, Antoine Lafuma, et al. · Ophthalmic Epidemiology · 25
Socioeconomic aspects of laser in situ keratomileusis, eyeglasses, and contact lenses in mild to moderate myopia
2002 · G. Berdeaux, Jorge L. Alió, et al. · Journal of Cataract & Refractive Surgery · 24
Evaluación de la eficiencia de la vacunación antigripal en la población laboral española
2006 · José Ramón de Juanes, Ramón Cisterna, et al. · Gaceta Sanitaria · 12
PDF
Cost-Effectiveness Analysis of Enfuvirtide (ENF) Added to an Optimized Therapy Compared with an Optimized Therapy in Patients with HIV/AIDS
2007 · X. Badia, L. Lizán, et al. · HIV Clinical Trials · 9
PDF
Cost-efficacy of oral triptans in the treatment of acute migraine
2005 · John Slof, Xavier Badia, et al. · Journal of Medical Economics · 4
PDF
Pcv62 Clinical and Economic Outcomes of Fondaparinux Vs. Enoxaparin in the Prophylaxis of Venous Thromboembolism After Major Orthopaedic Surgery in Spain
2003 · J Slof, S Magaz, et al. · Value in Health · 2
PDF
Pin16 Cost-effectiveness Analysis of Fuzeon Added to Optimal Standard Therapy Vs. Optimized Background Regimen Alone in Patients With Hiv/aids
2003 · D Serrano, S Magaz, et al. · Value in Health · 2
Pcv64 Cost-effectiveness Analysis of Coronary Revascularisation Techniques Available for the Treatment of Ischaemic Heart Disease
2003 · S Magaz, X Badia, et al. · Value in Health · 2
PDF
Integrated health outcomes research strategies in drug or medical device development, pre- and postmarketing: time for change
2002 · Xavier Badía, Alice Guyver, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2
Par9 a Cost Minimisation Analyse for Studying the Efficiency of Biologic Therapies (bt) in Rheumatoid Arthritis (ra). Overview for the Spanish Setting
2004 · X Badia, D Serrano, et al. · Value in Health · 1
Cost Minimization Analysis of Oral Valganciclovir Versus Intravenous and Oral Ganciclovir in the Prevention of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
2004 · F Oppenheimer, M Rubio, et al. · Transplantation · 1
Pin7 Cost Minimization Analysis of Oral Valganciclovir Vs. Intravenous and Oral Ganciclovir in the Prevention of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
2004 · M Rubio, F Oppenheimer, et al. · Value in Health
PDF
Par28 Assessing Intangibles in Biologic Therapies for Rheumatoid Arthritis (ra). a Willingness to Pay (wtp) Study in Spanish Patients
2004 · X Badia, D Serrano, et al. · Value in Health
PDF
Pdb28 Validation of Oral Antidiabetic Drugs Prescriptions: the Views of Primary Care Physicians
2004 · L Gutierrez, S Magaz, et al. · Value in Health
PDF
Rx1 Prescription Drug Information: a Survey of the General Population in Spain
2003 · X Badia, S Magaz, et al. · Value in Health
PDF
Puk6 Cost-minimization Analysis of Tensionfree Vaginal Tape Vs. Open Burch Colposuspension in Female Stress Urinary Incontinence
2003 · R Lahoz, S Magaz, et al. · Value in Health
Pae14 Cost-effectiveness Analysis of Pmma, Silicone, and Acrylic Intra-ocular Lenses in Cataract Therapy in Four European Countries
2003 · AF Smith, A Lafuma, et al. · Value in Health
PDF
Pin31 Cost-effectiveness Analysis of Oncedaily Modified Release Clarithromycin Versus Conventional Twice-daily Generic Clarithromycin for the Treatment of Respiratory Tract Infections
2003 · M Rubio, S Magaz, et al. · Value in Health
PDF
Pnm5 Management Costs of Chest and Cnsrelated Adverse Events of Triptans (serotonin 5-ht1b/1d Agonists) in Spain
2003 · J Slof, S Magaz, et al. · Value in Health
PDF
Costs and Consequences of Lasik, Glasses and Contact Lenses in Mild to Moderate Myopia: A Spanish Societal Approach
2003 · J Martínez, S Magaz, et al. · Investigative Ophthalmology & Visual Science
Pcn9 Cost-efficacy of Zoledronic 4mg Acid Vs. Pamidronate 90mg in the Treatment of Hypercalcemia of Malignacy (hcm)
2002 · X Badia, EJ Slof, et al. · Value in Health
PDF
Pnp6 the Burden of Migraine: Beyond Direct Health Care Costs
2002 · X Badia, S Magaz, et al. · Value in Health
PDF
Pee5: Costs and Consequences of Lasik, Glasses and Contact Lenses in Mild to Moderate Myopia—a Spanish Societal Approach
2001 · J Alio y Sanz, J Martinez, et al. · Value in Health
PDF
Pcn5: Evaluation of Three Different Methods of Assessing Willingness to Pay for a New Drug in the General Population
2000 · X Badia, J Pinto, et al. · Value in Health
Works count: 25
Citation count: 133
H-index: 5
I10-index: 4
Year
Topic
Type